Programme for Injectable Therapies for People with Type 2 Diabetes

June - November 2022 

Virtual Training Courses

A university accredited virtual promotional training course held over 2.5 days that supports healthcare professionals who are managing people with Type 2 diabetes on more complex regimens, including GLP-1 and insulin initiation.

Programme summary

Expect a variety of different topics on devices, insulins and other injectable therapies including:

  • Revision of diabetes oral medications
  • GLP-1 agonists including initiation using a structured care pathway
  • Detective work at review appointments focusing on injectables
  • Insulin safety (self-directed learning)
  • Working through the PITstop insulin pathway to assess for insulin, initiate an appropriate insulin regimen and support the patient for the first 6 months: a case study approach
  • Dietary considerations and insulin, including minimising weight gain
  • Embedding the learning and university accreditation

Who is this course suitable for?

GPs, Nurse Practitioners, Practice Nurses, Clinical Pharmacists and Physician Associates (who are working as part of a practice diabetes team), already experienced in providing a diabetes service.

New to post DSNs identified as requiring training at this level, may also be suitable for this course.

Delegates will have ideally attended a diabetes course to foundation level or be able to provide evidence of self-directed learning, focusing on the oral diabetes medication pathway.


If you are interested in attending a course and would like further information, please contact your local diabetes representative or alternatively provide your contact details here.

2022 Course Dates

Find below the dates for the 2 and a half day courses, starting in 2022.





7th and 8th

12th July 2022


7th and 14th

15th September 2022


8th and 9th

4th November 2022


7th and 14th

9th December 2022


9th and 10th

12th January 2022

This educational programme is funded and sponsored by Sanofi. The PITstop for Diabetes course content has been independently developed and will be delivered by PITstop for Diabetes on behalf of Sanofi. Sanofi have had no input or involvement in the creation of these materials but has reviewed the content to ensure compliance with the ABPI code of practice. Adverse event reporting and prescribing information is available at the meetings.

Date of Preparation: June 2022